期刊文献+

咖啡因N_1位水解去甲基反应机理的理论研究 被引量:1

Study on the Hydrolysis Demethylation Mechanisms of Position N_1 of Caffeine
下载PDF
导出
摘要 基于密度泛函理论,利用BH&HLYP/6-311++g(d,p)方法对咖啡因N1位水解去甲基机理进行了研究.主要考察了两条反应路径,路径A为O6氢转移机理,路径B为O2氢转移机理.计算结果表明,路径A略优于路径B,但两条反应路径均需较高的活化能(大于350 kJ·mol-1),因而很难直接通过水解脱去甲基,从而强调了酶的重要催化作用. The hydrolysis demethylation mechanisms of position N1 of caffeine were explored in this paper by density functional theory at the BH&HLYP/6-311 + + g(d,p) theory of level.Two pathways were investigated.Pathways A and B involved the O6 and O2 hydrogen transfer mechanisms,respectively.The calculated results show that pathway A is slightly more favorable than pathway B.However,the two pathways both involve high activation energies more than 350 kJ mol-1.Consequently,it is unfeasible for the demethylation of position N1 of caffeine via direct hydrolysis,which emphases the important catalytic role of enzyme.
出处 《西华师范大学学报(自然科学版)》 2014年第1期32-35,共4页 Journal of China West Normal University(Natural Sciences)
基金 国家自然科学基金项目(21203153 21173151) 四川省科技厅应用基础项目(2011JY0136) 四川省教育厅重点项目(12ZA174) 西华师范大学博士启动基金资助项目(11B002)
关键词 咖啡因 水解 去甲基反应 BH caffeine hydrolysis demethylation reaction BH&HLYP
  • 相关文献

参考文献11

  • 1BARREIRO E J, Kt:MMERLE A E,FRAGA C A M. The Methylation Effect in Medicinal Chemistry [ J]. Chem. Rev,2011,111 : 5215 - 5246.
  • 2IANCU I, STROUS R D. Caffeine Intoxication : History, Clinical Features, Diagnosis and Treatment [ J ], I-Iarefuah ,2006,145 : 147 - 164.
  • 3HENDRYCHOV: T,ANZENBACHEROV: E, HUDE(:EK J, et al. Flexibility of Human Cytochrome P450 Enzymes: Molecular and Spectroscopy Reveal Impdrtant Function-Related Variations [ J] ,Biochimica et Biophysica Acta,2011,1814 :58 -.
  • 4Dynamics 68. JUNG J, KIM N D, KIM S Y,et al. Regioselectivity Prediction of CYP1A2CMediated Phase I Metabolism [ J] ,J. Chem. Inf. Mod- el. ,2008,48 : 1074 - 1080.
  • 5ZHANG T,LIU L A,LEWIS D F V,et al. LongCRange Effects of a Peripheral Mutation on the Enzymatic Activity of Cytochrome P450 1A2 [J] ,J. Chem. Inf. Model,2011,51:1336 - 1346.
  • 6陈尧,周宏灏.咖啡因体内代谢及其应用的研究进展[J].生理科学进展,2010,41(4):256-260. 被引量:36
  • 7WANYIKA H N,GATEBE E G,GITU L M ,et al. Determination of Caffeine Content of Tea and Instant Coffee Brands Found in the Kenyan Market [ J] ,African Journal of Food Science,2010,4:353.'? 358.
  • 8DASH S S, GUMMAD S N. Catabolic Pathways and Biotechnological Applications of Microbial Caffeine Degradation [ J ], Bio- technol Lett,2006,28 : 1993 - 2002.
  • 9TIMOTHY S T, RAMAN V, DOUGLAS D G,et al. Temporal Changes in Drug Metabolism (CYPI A2, CYP2D6 and CYP3A Activ- ity) during Pregnancy [ J], American Journal of Obstetrics and Gynecology ,2005,192 : 633 - 639.
  • 10CHEN Z Q,ZHANG C H,XUE Y. Theoretical Studies on the Thermodynamics and Kinetics of the NCglycosidic Bond Cleavage in Deoxythymidine Glycol [ J]. J Phys Chem B ,2009,113 : 10409 - 10420.

二级参考文献2

共引文献35

同被引文献11

  • 1ASHIHARA H, SUZUKI T. Distribution and Biosynthesis of Caffeine in Plants [J] . Front Biosci, 2004 , 9 : 1864 - 1876.
  • 2DAVIS J M, ZHAO Z,STOCK H S, et al. Central Nervous System Effects of Caffeine and Adenosine on Fatigue [J] . AmPhysiol Regul Integr Comp Physiol, 2003 , 284(2) : R399 -404.
  • 3RIBEIRO J A, SEBASTlAO A M. Caffeine and Adenosine [J]. J. Alzheimers Dis. 2010,20 suppl 1(4) : S3 -S15.
  • 4BOROTA D,MURRAY E, KECELI G,et al. Post-study caffeine administration enhances memory consolidation in humans[J]. Nat Neurosci, 2014,17(2) ; 201 -203.
  • 5DING M,BHUPATHIRAJU S N ,SATIJA A,et al. Long-term coffee consumption and risk of cardiovascular disease a systematicreview and a dose-response meta-analysis of prospective cohort studies[J]. Circulation,2014,129(6) :643 - 659.
  • 6VAN DAM R M. Coffee consumption and risk of type 2 diabetes, cardiovascular diseases, and cancer [J]. Appl Physiol NutrMetab, 2008, 33(6) : 1269 - 1283.
  • 7ARAB L. Epidemiologic evidence on coffee and cancer [J]. Nutr Cancer, 2010,62: 271 — 283.
  • 8BARNES P J. Theophiline [J]. Am J Respir Crit Med, 2013 , 188 ; 901 -906.
  • 9ORRtJ M,GUITART X, KARCZ-KUBICHA M,et al. Psychostimulant pharmacological profile of paraxanthine,the main me-tabolite of caffeine in humans [J]. Neuropharmacology, 2013,67: 476 -484.
  • 10FRISH M J, TRUCKS G W,SCHLEGEL H B, et al. Gaussian 09, revision D01,Gaussian, Inc. : Wallingford CT, 2013.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部